| 6 | Analgesics (Analgesic Drugs)IBA
06/2009
-
12/2000 |
| 3 | CannabinoidsIBA
06/2009
-
01/2008 |
| 3 | Freund's AdjuvantIBA
11/2006
-
01/2000 |
| 3 | OsteoprotegerinIBA
05/2001
-
05/2000 |
| 2 | Capsaicin (Zostrix)FDA Link
12/2006
-
09/2006 |
| 1 | Cannabinoid Receptor AgonistsIBA
06/2009 |
| 1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
06/2009 |
| 1 | mu Opioid Receptors (mu Opioid Receptor)IBA
01/2008 |
| 1 | CB2 Cannabinoid ReceptorIBA
01/2008 |
| 1 | (1- (2- morpholin- 4- yl- ethyl)- 1H- indol- 3- yl)- (2,2,3,3- tetramethylcyclopropyl)methanoneIBA
01/2008 |
| 1 | Formaldehyde (Formol)FDA Link
06/2007 |
| 1 | Purinergic P2X7 ReceptorsIBA
06/2007 |
| 1 | Purinergic P2 Receptors (ADP Receptor)IBA
06/2007 |
| 1 | 3- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA
06/2007 |
| 1 | Gabapentin (Neurontin)FDA LinkGeneric
12/2006 |
| 1 | Lamotrigine (Lamictal)FDA LinkGeneric
12/2006 |
| 1 | Morphine (MS Contin)FDA LinkGeneric
12/2006 |
| 1 | Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2006 |
| 1 | metabotropic glutamate receptor type 1IBA
11/2006 |
| 1 | A-841720IBA
11/2006 |
| 1 | CationsIBA
09/2006 |
| 1 | LipidsIBA
09/2006 |
| 1 | PyrrolidinesIBA
09/2006 |
| 1 | TRPV Cation ChannelsIBA
09/2006 |
| 1 | N- 1H- indazol- 4- yl- N'- (5- piperidin- 1- yl- 2,3- dihydro- 1H- inden- 1- yl)ureaIBA
09/2006 |
| 1 | 1- (3- (trifluoromethyl)pyridin- 2- yl)- N- (4- (trifluoromethylsulfonyl)phenyl)- 1,2,3,6- tetrahydropyridine- 4- carboxamideIBA
09/2006 |
| 1 | Urea (Carbamide)FDA LinkGeneric
09/2006 |
| 1 | LigandsIBA
09/2006 |
| 1 | Dental AmalgamIBA
05/2001 |
| 1 | GalaninIBA
01/2000 |
| 1 | Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2000 |
| 1 | Calcitonin Gene-Related PeptideIBA
01/2000 |
| 1 | Substance PIBA
01/2000 |
| 1 | Dynorphins (Dynorphin)IBA
01/2000 |
| 1 | Neuropeptide YIBA
01/2000 |
| 1 | protein kinase C gamma (PRKCG)IBA
01/2000 |